Skip to main navigation
Close
Menu
Main navigation
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action
Breadcrumb
Association for Accessible Medicines
Resources
Resources
Share
Find up-to-date information on generics and biosimilars
Filter Resources
Issues
Biosimilar User Fee Act (BsUFA)
Biosimilars
Complex Generics
Drug Approval Process (GDUFA)
Drug Prices
Drug Shortages
Generic Drug Labeling
Generic Supply Chain
IP Issues
Low Income Subsidies (LIS in Part D)
Medicaid
Medicare
NAFTA
Patent Reform
Patient Stories
Pharmaceutical Waste Take Back
Preventing Drug Abuse
Quality
REMS/Sample Acquisition Remedies
State Initiatives
Tariffs
Trade
Transparency
User Fees
Resource Type
Blog
Amicus Brief
Press Release
Infographic
Video
Report
Fact Sheet
Presentation
Video
Apr 17, 2019
| Erica Klinger
Generic Medicines: Take With Confidence (Rich)
Video
Apr 11, 2019
| Erica Klinger
Generic Medicines: Take With Confidence (Jonnie)
Press Release
Apr 3, 2019
| Rachel Schwartz
AAM Statement on House Energy & Commerce Passage of the CREATES Act
Video
Apr 2, 2019
| Jonathan Kimball
NAFTA 2.0: Obstacles to More Affordable Meds
Press Release
Apr 1, 2019
| Rachel Schwartz
AAM Response to CMS Final 2020 Call Letter
Blog
Apr 1, 2019
| Jonathan Kimball
NAFTA 2.0: 3 Obstacles to More Affordable Medicines in the U.S.
Blog
Mar 28, 2019
| Erica Klinger
AAM Wins Bronze Award from Association TRENDS
Fact Sheet
Mar 28, 2019
| Erik Komendant
Patent Settlements DO Help Patients
Press Release
Mar 27, 2019
| Rachel Schwartz
AAM Statement: 2019 Energy and Commerce Health Subcommittee Markup
Infographic
Mar 26, 2019
| Erica Klinger
NAFTA 2.0: Obstacles to More Affordable Medicines
Press Release
Mar 18, 2019
| Rachel Schwartz
Karin Hessler Joins AAM as Assistant General Counsel
Press Release
Mar 11, 2019
| Rachel Schwartz
AAM Statement in Response to Administration's FY 2020 Budget Proposal
Load More
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2024
GRx+Biosims 2023
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action